Real-time enrollment status for this proliferative diabetic retinopathy clinical trial
Current Status
Recruiting
Checked: October 21, 2026 at 10:08 PM UTC
| NCT Number | NCT06790784 |
| Recruiting Status | Recruiting |
| Condition | Proliferative Diabetic Retinopathy |
| Phase | PHASE3 |
| Target Enrollment | 426 participants |
| Active Locations | 34 sites in the US |
| Sponsor | Jaeb Center for Health Research |
| Last Updated on CT.gov | September 18, 2026 (Sep 18, 2026) |
As of October 21, 2026: Clinical trial NCT06790784 is currently recruiting participants. This phase3 study for proliferative diabetic retinopathy is actively seeking new participants at 34 locations across the United States. The study is sponsored by Jaeb Center for Health Research. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06790784 is actively recruiting participants as of October 21, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 34 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06790784 was last updated Sep 18, 2026 (September 18, 2026). HelloStudys verifies this status automatically.